Foster Corporation is a leading player in the field of custom biomedical polymer compounding with a history spanning over three decades, having been established in 1989. The company prides itself on offering market-leading technology and services to medical device manufacturers, operating within ISO 13485:2016 and ISO 14001:2015 certified facilities. Foster Corporation specializes in expert formulation development and production of polymer enhancements, including radiopaque fillers, custom colors, and other specialty additives to support class I, II, and III medical device applications. Additionally, the company boasts a dedicated business unit, Foster Supply Chain Solutions, reflecting a commitment to comprehensive service provision. This makes Foster Corporation a strong contender in the industrial and manufacturing sectors. Although specific details regarding the last investment and associated investors are currently unavailable, the company's extensive experience and specialized focus position it as a potential candidate for investment within the burgeoning medical and industrial sectors.
There is no investment information
No recent news or press coverage available for Foster Corporation.